PRODH and non-small cell lung carcinoma: In epigenome-wide methylation–age interaction analysis aimed to identify age-specific, prognosis-associated epigenetic biomarkers in NSCLC patients, PRODH promoter methylation was the only identified factor that interacted with age to affect prognosis.